StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Protagenic Therapeutics, Inc.new's revenue for the twelve months ending Dec 31, 2024 was $0. For fiscal 2024 it was $0. The highest annual figure on record is $0 in fiscal 2016.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0–
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0–
FY2016Dec 31, 2016$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ4 2024Dec 31, 2024$0–
Q3 FY2024CQ3 2024Sep 30, 2024$0–
Q2 FY2024CQ2 2024Jun 30, 2024$0–
Q1 FY2024CQ1 2024Mar 31, 2024$0–
Q4 FY2023CQ4 2023Dec 31, 2023$0–
Q3 FY2023CQ3 2023Sep 30, 2023$0–
Q2 FY2023CQ2 2023Jun 30, 2023$0–
Q1 FY2023CQ1 2023Mar 31, 2023$0–
Q4 FY2022CQ4 2022Dec 31, 2022$0–
Q3 FY2022CQ3 2022Sep 30, 2022$0–
Q2 FY2022CQ2 2022Jun 30, 2022$0–
Q1 FY2022CQ1 2022Mar 31, 2022$0–
Q4 FY2021CQ4 2021Dec 31, 2021$0–
Q3 FY2021CQ3 2021Sep 30, 2021$0–
Q2 FY2021CQ2 2021Jun 30, 2021$0–
Q1 FY2021CQ1 2021Mar 31, 2021$0–
Q4 FY2020CQ4 2020Dec 31, 2020$0–
Q3 FY2020CQ3 2020Sep 30, 2020$0–
Q3 FY2017CQ3 2017Sep 30, 2017$0–
Q2 FY2017CQ2 2017Jun 30, 2017$0–
Q1 FY2017CQ1 2017Mar 31, 2017$0–
Q4 FY2016CQ4 2016Dec 31, 2016$0–
Q3 FY2016CQ3 2016Sep 30, 2016$0–
Q2 FY2016CQ2 2016Jun 30, 2016$0–
Q1 FY2016CQ1 2016Mar 31, 2016$0–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?